HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Likun Du Selected Research
Likun Du Research Topics
Disease
8
COVID-19
02/2024 - 01/2022
6
Infections
01/2024 - 11/2007
6
Neoplasms (Cancer)
01/2022 - 02/2012
3
Ataxia Telangiectasia (Louis Bar Syndrome)
01/2024 - 01/2006
3
Inflammation (Inflammations)
08/2022 - 11/2007
2
Lymphoma (Lymphomas)
12/2022 - 01/2022
2
COVID-19 related pediatric multisystem inflammatory disease
11/2022 - 01/2022
2
Fibrosis (Cirrhosis)
08/2022 - 01/2019
2
Asthma (Bronchial Asthma)
05/2022 - 01/2022
2
Common Variable Immunodeficiency
11/2020 - 11/2009
1
Breakthrough Infections
01/2024
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2022
1
Epstein-Barr Virus Infections
12/2022
1
Diabetes Complications
08/2022
1
Pneumonia (Pneumonitis)
01/2022
1
Inborn Genetic Diseases (Disease, Hereditary)
01/2022
1
Rhinitis
01/2022
1
Neoplasm Metastasis (Metastasis)
01/2020
1
Lung Neoplasms (Lung Cancer)
01/2020
1
Diabetic Nephropathies (Diabetic Nephropathy)
01/2019
1
Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
12/2016
1
Breast Neoplasms (Breast Cancer)
02/2015
1
Fanconi Anemia (Fanconi's Anemia)
02/2015
1
De Lange Syndrome (Cornelia De Lange Syndrome)
11/2013
1
IgA Deficiency
04/2007
Drug/Important Bio-Agent (IBA)
6
Proteins (Proteins, Gene)
FDA Link
12/2022 - 01/2006
4
Autoantibodies
IBA
02/2024 - 01/2022
4
Immunoglobulins (Immunoglobulin)
IBA
01/2024 - 01/2009
4
Antibodies
IBA
11/2022 - 01/2009
3
Immunoglobulin A (IgA)
IBA
01/2024 - 02/2012
2
Interferon Type I
IBA
02/2024 - 01/2022
2
mRNA Vaccines
IBA
01/2024 - 01/2022
2
Immunoglobulin G (IgG)
IBA
01/2024 - 01/2022
2
Angiotensin-Converting Enzyme 2
IBA
01/2024 - 10/2023
2
Long Noncoding RNA
IBA
08/2022 - 01/2019
2
Collagen
IBA
08/2022 - 01/2019
2
Cytokines
IBA
08/2022 - 01/2019
2
Fibronectins (Fibronectin)
IBA
08/2022 - 01/2019
2
Immunoglobulin M (IgM)
IBA
01/2022 - 01/2022
1
Secretory Immunoglobulin A (SIgA)
IBA
01/2024
1
DXP-604
IBA
01/2024
1
Immune Checkpoint Inhibitors
IBA
12/2022
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
08/2022
1
Glucose (Dextrose)
FDA Link
Generic
08/2022
1
Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
IBA
08/2022
1
Small Interfering RNA (siRNA)
IBA
08/2022
1
MicroRNAs (MicroRNA)
IBA
08/2022
1
Catenins
IBA
08/2022
1
Caspase 3 (Caspase-3)
IBA
08/2022
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
05/2022
1
Vaccines
IBA
02/2022
1
Antiviral Agents (Antivirals)
IBA
02/2022
1
Immunoglobulin E (IgE)
IBA
01/2022
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
01/2022
1
Angiotensins
IBA
01/2022
1
Inactivated Vaccines
IBA
01/2022
1
Therapeutic Uses
IBA
12/2020
1
Piwi-Interacting RNA
IBA
01/2020
1
Interleukins
IBA
01/2019
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2019
1
Annexin A5
IBA
01/2019
1
Propidium (Propidium Iodide)
IBA
01/2019
1
Interleukin-6 (Interleukin 6)
IBA
01/2019
1
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
12/2016
1
BRCA1 Protein
IBA
02/2015
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
02/2015
1
Deoxyribonuclease I (Nickase)
IBA
02/2015
1
Cohesins
IBA
11/2013
1
DNA Ligase ATP
IBA
03/2009
1
DNA-Activated Protein Kinase
IBA
03/2009
1
Cytidine Deaminase
IBA
01/2009
1
Virulence Factors (Pathogenicity Factors)
IBA
11/2007
1
DNA (Deoxyribonucleic Acid)
IBA
04/2007
Therapy/Procedure
1
Intranasal Administration
01/2024
1
Therapeutics
01/2022